➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Colorcon
Moodys
Johnson and Johnson
AstraZeneca

Last Updated: May 27, 2020

DrugPatentWatch Database Preview

Inspirion Delivery Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for INSPIRION DELIVERY, and what generic alternatives to INSPIRION DELIVERY drugs are available?

INSPIRION DELIVERY has one approved drug.

There are two US patents protecting INSPIRION DELIVERY drugs.

There are twenty-two patent family members on INSPIRION DELIVERY drugs in ten countries and one supplementary protection certificate in one country.

Summary for Inspirion Delivery
International Patents:22
US Patents:2
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Inspirion Delivery

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Inspirion Delivery ROXYBOND oxycodone hydrochloride TABLET;ORAL 209777-002 Apr 20, 2017 DISCN No No   Start Trial   Start Trial
Inspirion Delivery ROXYBOND oxycodone hydrochloride TABLET;ORAL 209777-003 Apr 20, 2017 DISCN No No   Start Trial   Start Trial
Inspirion Delivery ROXYBOND oxycodone hydrochloride TABLET;ORAL 209777-003 Apr 20, 2017 DISCN No No 7,955,619   Start Trial Y   Start Trial
Inspirion Delivery ROXYBOND oxycodone hydrochloride TABLET;ORAL 209777-001 Apr 20, 2017 DISCN No No 10,314,788   Start Trial Y   Start Trial
Inspirion Delivery ROXYBOND oxycodone hydrochloride TABLET;ORAL 209777-003 Apr 20, 2017 DISCN No No 10,314,788   Start Trial Y   Start Trial
Inspirion Delivery ROXYBOND oxycodone hydrochloride TABLET;ORAL 209777-002 Apr 20, 2017 DISCN No No 7,955,619   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Inspirion Delivery Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1685839 92292 Luxembourg   Start Trial PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Medtronic
AstraZeneca
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.